2-Amino-4-(4-bromophenyl)thiazole (CAS 2104-09-8, molecular formula C₉H₇BrN₂S, molecular weight 255.14 g·mol⁻¹) operates as a heterobifunctional building block where the 2-amino moiety and the 4-(4-bromophenyl) substituent confer orthogonal reactivity. The thiazole ring positions the bromine atom at the para site of the pendant phenyl group, enabling oxidative addition with palladium(0) catalysts under conditions sufficiently mild to preserve the free amine, which itself participates in acylation, sulfonylation, and urea formation. Commercial material is typically supplied as a crystalline solid with a melting point of 156–158 °C and is assayed at ≥98.0% purity by reversed-phase HPLC (C18 column, acetonitrile/0.1% trifluoroacetic acid gradient, UV detection at 254 nm). Residual solvent content is controlled according to USP <467> Class 2 solvent limits, and heavy metals are governed by a Method 2 screening compliant with the current harmonized edition of Ph. Eur. 2.4.8.
What Distinguishes the 4-Bromophenyl Substituent in Cross-Coupling Reactivity?
The bromine atom serves as the primary electrophilic exit vector in palladium-catalyzed transformations. Under Suzuki–Miyaura conditions employing Pd(PPh₃)₄ at 0.5 mol% loading and aqueous sodium carbonate in 1,4-dioxane at 90 °C, oxidative addition proceeds with a rate constant that is approximately 5-fold higher than that of the corresponding 4-chlorophenyl analog, as measured by in situ ReactIR monitoring of the carbon–halogen stretching region. In contrast, the 4-iodophenyl congener reacts roughly 2.5-fold faster but introduces both higher raw-material cost and an elevated risk of dehalogenation side reactions when the coupling partner contains electron-deficient aryl boronic acids. This balance of kinetic accessibility and minimised proto-dehalogenation makes the brominated variant the preferred intermediate in library syntheses where diverse biaryl linkages are generated from a common stock solution. For Buchwald–Hartwig aminations, the bromide engages effectively with XantPhos-palladium precatalysts at 80–100 °C in toluene, tolerating the free 2-amino group without requiring in situ silyl protection.
Specification Profile and Quality Control Parameters
Batch analysis certificates for kilogram-scale deliveries routinely report the parameters aggregated in the table below. Acceptance criteria are aligned with the ICH Q3A guideline thresholds for intermediates intended for further chemical transformation into active pharmaceutical ingredients.
| Parameter | Method | Acceptance Limit |
|---|---|---|
| Assay (anhydrous basis) | HPLC (C18, gradient, 254 nm) | ≥98.0% area |
| Melting point | ASTM E324 capillary | 156–158 °C |
| Water content | Karl Fischer coulometric | ≤0.5% w/w |
| Residue on ignition | Ph. Eur. 2.4.14, 600 °C | ≤0.10% |
| Palladium content | ICP-MS (m/z 105, 108) | ≤10 ppm |
| Total unidentified impurities | HPLC as above | ≤0.5% each, ≤1.0% total |
| Residual solvents (dioxane, DMF) | GC-FID, USP <467> Procedure A | Class 2 limits per ICH Q3C |
A single impurity commonly detected at the 0.1–0.2% level is 2-amino-4-phenylthiazole, arising from debromination during the Hantzsch cyclisation step. Its removal below 0.05% is achievable through trituration in cold ethanol but is unnecessary for most subsequent coupling reactions where the homodimeric side product formed from debrominated starting material precipitates selectively from the post-reaction mixture during workup.
For pilot-scale Suzuki coupling employing Pd(PPh₃)₄ at 0.5 mol% loading, the substrate stoichiometry and base selection must be calibrated to the water content of the thiazole monomer. When the Karl Fischer value exceeds 0.3%, the rate of boronic acid protodeboronation accelerates measurably, decreasing the isolated yield by 6–12% at full conversion. A pre-reaction azeotropic drying cycle with toluene (40 °C, 50 mbar, rotary evaporator) is therefore specified in the in-house manufacturing directive when relative humidity in the dispensing suite exceeds 60%. The free amine of the thiazole does not require inert-atmosphere handling during short-term weighing; however, solutions in chlorinated solvents exposed to ambient light discolor within 4–6 hours, forming a violet chromophore attributed to a charge-transfer complex with halogenated solvent radicals. Storing stock solutions under amber glass or wrapping the vessel in aluminium foil effectively blocks this pathway.
When Storage Conditions Deviate from –20°C Under Inert Atmosphere
The bulk solid is hygroscopic; prolonged exposure to air at relative humidity above 65% produces a monohydrate phase detectable by a shift in the carbonyl-breathing region (1640 cm⁻¹ to 1618 cm⁻¹) of the FTIR spectrum. The hydrate dissociates upon drying at 40 °C under vacuum for 24 h, but repeated hydration-dehydration cycles increase the content of the debrominated impurity by 0.2–0.4% per cycle, likely through a radical-mediated pathway facilitated by lattice water. Long-term stability studies conducted per ICH Q1A(R2) conditions (25 °C/60% RH, 40 °C/75% RH) indicate 0.3% assay loss per month at the accelerated condition, with a dish-shaped degradation rate versus temperature profile that flattens below –20 °C. Consequently, kilogram-quantity inventory intended for active pharmaceutical ingredient campaigns is packaged in double polyethylene bags inside fibre drums, with a 500 g silica-gel desiccant sachet, and stored in a freezer set to –20 ± 5 °C. Before use, containers are equilibrated to ambient temperature inside a nitrogen-purged glove bag to prevent condensation.
Evaluating Purity Profiles Across Different Synthetic Routes
Two principal manufacturing routes yield the compound. The dominant large-scale process condenses 4-bromophenacyl bromide with thiourea in refluxing ethanol, followed by neutralisation with aqueous ammonia. This route generates a product stream containing 2–5% of the 5-bromo regioisomer if the condensation exotherm is not controlled below 60 °C. The isomer ratio is measurable by 1H NMR integration of the thiazole C5 proton singlet (δ 6.79 ppm for the target isomer versus δ 6.92 ppm for the 5-bromo isomer in DMSO-d₆). An alternative pathway through cyclisation of 4-bromobenzaldehyde with cyanamide and sulfur in the presence of a tertiary amine produces a regioisomerically cleaner product (<0.3% 5-isomer) but introduces a cyanamide-derived byproduct that requires column chromatography or fractional crystallisation from toluene/heptane to achieve the 98% HPLC threshold. The cost–purity trade-off dictates that the thiourea route serves the majority of discovery purchases, while the cyanamide route is reserved for late-stage process validation runs where the 5-bromo isomer interferes with chiral phase-transfer catalytic steps downstream.
The compound’s amination at the 2-position provides a nucleophilic site for urea and amide bond formation, a property exploited in the construction of kinase inhibitor libraries targeting the DFG-out conformation of type II inhibitors. The bromophenyl group has been used to install oxazole, pyrazole, and aniline moieties via sequential Suzuki cross-coupling and Chan–Lam etherification, demonstrating a tolerance for aqueous alkaline and mildly acidic conditions without ring-opening of the thiazole core. A comparison of key reactivity attributes with structurally related 2-aminothiazoles is provided in the following table.
| Derivative | Relative Suzuki ratea | Proto-dehalogenationb | Crude purityc | Approx. bulk costd |
|---|---|---|---|---|
| 2-Amino-4-(4-bromophenyl)thiazole | 1.0 (reference) | <2% | 94–97% | moderate |
| 2-Amino-4-(4-chlorophenyl)thiazole | 0.18–0.22 | <1% | 91–93% | lower |
| 2-Amino-4-(4-iodophenyl)thiazole | 2.3–2.8 | 5–8% | 85–90% | higher |
| 2-Amino-4-phenylthiazole | N/A (no halogen) | N/A | 96–98% | lower |
a Relative initial oxidative addition rate, Pd(PPh₃)₄ 0.5 mol%, phenylboronic acid 1.2 eq, Na₂CO₃ 2 eq, 1,4-dioxane/water 4:1, 90 °C.
b Molar percentage of dehalogenated side product at full conversion by GC-MS.
c HPLC area% before purification.
d Qualitative comparison based on typical catalogue pricing per kilogram.
Regulatory compliance is supported by documentation consistent with REACH requirements for substances manufactured or imported at quantities above 1 metric ton per annum. A substance volume tracking report is maintained for each shipment to the European Economic Area, and the material is classified under the Globally Harmonized System as Skin Irritant Category 2 and Eye Irritant Category 2A, with precautionary statements P264, P280, and P305+P351+P338 assigned based on OECD Test Guideline 439 and 437 outcomes. The absence of hydrazine and its derivatives in the supply chain is verified quarterly by HPLC post-column derivatisation with p-dimethylaminobenzaldehyde, achieving a reporting threshold of 1 ppm. For applications positioned under an FDA Drug Master File, Type II or Type III, the current synthetic route description and impurities dossier are maintained at the manufacturer’s site and cross-referenced with DMF submission number 034XXX (proprietary).